Pilot Study on the Efficacy and Safety of FIBRORESTIL® as an Adjuvant Intralesional Treatment in Patients With Peyronie's Disease Receiving Standard Therapy
Pilot Study on the Efficacy and Safety of FIBRORESTIL® as an Adjuvant Intralesional Treatment in Patients With Peyronie's Disease Receiving Standard Therapy
Active, not recruiting · NCT07341529 · Registry updated 2026-01-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pilot Study on the Efficacy and Safety of FIBRORESTIL® as an Adjuvant Intralesional Treatment in Patients With Peyronie's Disease Receiving Standard Therapy | Genital Diseases, Male Urogenital Diseases, Peyronie disease, Skin and Connective Tissue Diseases, Urogenital Diseases, connective tissue disorder, male reproductive system disorder, penile disorder | Active, not recruiting | Not applicable | 2026-01-14 | NCT07341529 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lyx Institute | 1 |
| Lyx Institute of Urology | 1 |
| Lyx Institution | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Universitario La Paz (HULP) | Madrid | Spain | 1 |
| Lyx Institute of Urology | Madrid | Spain | 1 |